Recent progress on the role of gut microbiota in the pathogenesis of inflammatory bowel disease

@article{Yu2013RecentPO,
  title={Recent progress on the role of gut microbiota in the pathogenesis of inflammatory bowel disease},
  author={Cheng-gong Yu and Qin Huang},
  journal={Journal of Digestive Diseases},
  year={2013},
  volume={14}
}
In recent years investigations of inflammatory bowel disease (IBD) have advanced rapidly with regard to the relationship between the host immune response and gut microbiota. Patients with IBD have been shown to have an abnormal composition of gut microbiota and host immune dysregulation. Abnormal components of gut microbiota, to which the host mounts aberrant immune responses in genetically vulnerable individuals, appear to play a critical role in the pathogenesis of IBD. Therefore… 
Gut microbiota and inflammatory bowel disease: The current status and perspectives
TLDR
The effect of the gut microbiome in treating patients with IBD is discussed and the possible curative effect of microbiome-modulating interventions are discussed.
Proteomic insights on the metabolism in inflammatory bowel disease
TLDR
Proteomics represents a useful tool to enhance biological understanding and to discover biomarkers in blood and intestinal specimens and is expected to provide reproducible and quantitative data that can support clinical assessments and help clinicians in the diagnosis and treatment of IBD.
Systems biology in inflammatory bowel diseases: ready for prime time
TLDR
A systems biology approach could potentially identify the central regulators (hubs) in the IBD interactome and improve the understanding of the molecular mechanisms involved in IBD pathogenesis.
The autoimmunity-oral microbiome connection.
TLDR
This review article discusses links of the oral microbiota to a group of autoimmune diseases, that is, Sjögren's syndrome, systemic lupus erythematosus (SLE), Crohn's disease (CD), and rheumatoid arthritis (RA), and focuses on factors that affect the balance between the immune system and the composition of microbiota leading to dysbiosis, loss of tolerance and subsequent autoimmune disease progression and maintenance.
C URRENT OPINION Systems biology in inflammatory bowel diseases: ready for prime time
TLDR
A systems biology approach could potentially identify the central regulators (hubs) in the IBD interactome and improve the understanding of the molecular mechanisms involved in IBD pathogenesis.
A study on three aspects of Inflammatory Bowel Disease's Triad of Susceptibility: Hormones, Helminths and T regulatory cells, in the Helicobacter hepaticus mouse model for IBD
TLDR
The research presented here evaluates one aspect from each of the three susceptibility categories (genetics, environment and immune system) utilizing the H. hepaticus mouse model for IBD.
Mechanism and therapeutic effects of Saccharomyces boulardii on experimental colitis in mice
TLDR
Results indicated that treatment with S. boulardii ameliorated DSS-induced colitis, partly through downregulation of Hif-1α and HIF-2α and prevented the increase in HIFs in the colon induced by DSS was significantly inhibited by S.boulardius treatment.
Products for the treatment of inflammatory bowel disease: a patent review (2013 – 2014)
TLDR
Methods and strategies using new formulations of conventional drugs, guanylyl cyclase C peptide agonists, compounds that influence anti-adhesion molecules, mAbs anti-type I interferons and anti-integrin, oligonucleotide antisense Smad7, growth factor neuregulin 4 and functional foods are promising products for use in the very near future.
Clostridium difficile and inflammatory bowel disease: role in pathogenesis and implications in treatment.
TLDR
The aim of this paper is to review recent data on CDI in IBD: role in pathogenesis, diagnostic methods, optional treatments, and outcomes of these patients.
...
1
2
3
...

References

SHOWING 1-10 OF 41 REFERENCES
Host-microbiota interactions in inflammatory bowel disease
TLDR
The innate, adaptive, and regulatory immune response to the microbiota is discussed in the context of the mouse and human genes that are involved in maintaining intestinal homeostasis and preventing inflammation.
Dysbiosis in the Pathogenesis of Pediatric Inflammatory Bowel Diseases
TLDR
Microbial dysbiosis in IBD with lack of beneficial bacteria, together with genetic predisposition, is the most relevant conditions in the pathogenesis of the pediatric IBD.
The gut microbiota in IBD
TLDR
Dysbiosis (that is, abnormal microbiota composition) and decreased complexity of the gut microbial ecosystem are common features in patients with Crohn's disease or ulcerative colitis, and whether such changes are a cause or a consequence of the disease remains to be elucidated.
The gut microflora and its variety of roles in health and disease.
TLDR
An overview of the intestinal microbiota and its variety of roles in health and disease is given.
The role of bacteria in the pathogenesis of inflammatory bowel disease.
TLDR
The response to antitumor necrosis factor treatments suggests that, if relevant at all, MAP is not acting as a conventional pathogen, but there is increased colonization by MAP in CD, and there is evidence that it could have an indirect effect mediated by the suppression of macrophage function.
Role of Endogenous Microbiota, Probiotics and Their Biological Products in Human Health
TLDR
The potential for probiotics, with an emphasis on probiotic-derived factors, to reduce the severity of digestive diseases is addressed and the known mechanisms by which probiotics and probiotic -derived factors exert their physiological effects are discussed.
Probiotics in the mechanism of protection against gut inflammation and therapy of gastrointestinal disorders.
TLDR
A growing body of experimental and clinical evidence supports the hypothesis that the intestinal microbiota markedly influences function and the structure of the mucosal lining, and new exciting advances in the role of these microbes in the pathogenesis, management and treatment of gastrointestinal disorders are overview.
...
1
2
3
4
5
...